Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
PGAP2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
PACS2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
FAM50A - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARHGAP17 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
LMF1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC27A1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ELMOD3 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SLC25A29 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
WASH1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SEMA4C - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
PCSK7 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
SMG9 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ATP13A1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
ARAP1 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
LZTS2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
RBM10 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
NFASC - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
UBE2G2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
CRELD2 - Antiretroviral therapy effect on brain of patients with HIV-associated neurocognitive disorders
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on